NCT06001268 Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)
| NCT ID | NCT06001268 |
| Status | Recruiting |
| Phase | — |
| Sponsor | H. Lee Moffitt Cancer Center and Research Institute |
| Condition | Pancreatic Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2023-08-14 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2023-08-14 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to assess the feasibility and participant satisfaction with the Support through Remote Observation and Nutrition Guidance program. The program provides enhanced dietician access and nutrition support for participants living with pancreatic cancer who are undergoing surgery.
Eligibility Criteria
Inclusion Criteria: * ≥18 years old * Diagnosis of pancreatic cancer * Completed open pancreatic surgery (e.g., Whipple, distal/subtotal pancreatectomy, total pancreatectomy) for treatment at Moffitt Cancer Center * Discharged on an oral diet * Able to speak and read English or Spanish * Able to provide informed consent Exclusion Criteria: * Determined to be ineligible for surgery during evaluation (e.g., cancer metastasis)
Contact & Investigator
Kea Turner, PhD
PRINCIPAL INVESTIGATOR
Moffitt Cancer Center
Frequently Asked Questions
Who can join the NCT06001268 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreatic Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06001268 currently recruiting?
Yes, NCT06001268 is actively recruiting participants. Contact the research team at emma.hume@moffitt.org for enrollment information.
Where is the NCT06001268 trial being conducted?
This trial is being conducted at Tampa, United States.
Who is sponsoring the NCT06001268 clinical trial?
NCT06001268 is sponsored by H. Lee Moffitt Cancer Center and Research Institute. The principal investigator is Kea Turner, PhD at Moffitt Cancer Center. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.